Showing results (421-430 of 466) with videos related to

Sort By:
Pageof 47
The Lancet. Respiratory Medicine|January 7, 2021
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trialKristin B Highland, Oliver Distler, Masataka Kuwana, et al.
RMD Open|February 10, 2025
How to build a framework to establish a patient research partner network in rheumatology research: a report of a 2-year implementation projectKristina Buerki, Melpomeni Toitou, Maarten de Wit, et al.
The Lancet. Rheumatology|January 24, 2024
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohortMuriel Elhai, Nanthara Sritharan, Marouane Boubaya, et al.
Swiss Medical Weekly|July 20, 2021
The burden of systemic sclerosis in Switzerland - the Swiss systemic sclerosis EUSTAR cohortJasmin Hernández, Suzana Jordan, Rucsandra Dobrota, et al.
Rheumatology (Oxford, England)|July 29, 2022
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC modelAlexandru Garaiman, Klaus Steigmiller, Catherine Gebhard, et al.
Seminars in Arthritis and Rheumatism|September 11, 2023
The phenotype of mixed connective tissue disease patients having associated interstitial lung diseaseGonçalo Boleto, Silje Reiseter, Anna-Maria Hoffmann-Vold, et al.
The Lancet. Rheumatology|February 3, 2025
Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trialHåvard Fretheim, Imon Barua, Gunnstein Bakland, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 3, 2016
National outbreak of Yersinia enterocolitica infections in military and civilian populations associated with consumption of mixed salad, Norway, 2014Emily MacDonald, Margot Einöder-Moreno, Katrine Borgen, et al.
European Journal of Internal Medicine|April 10, 2024
Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature reviewA Dima, M C Vonk, A Garaiman, et al.
Rheumatology (Oxford, England)|January 8, 2025
Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohortEliane Roth, Cosimo Bruni, Liubov Petelytska, et al.
Pageof 47